AJNN
Academic Journal of Neuropsychiatry and Neuropsychology

Academic Journal of Neuropsychiatry and Neuropsychology (formerly known as the Academic Journal of Neurology and Neurosurgery, e-ISSN:3023-6517), deals with neurology, neurosurgery, psychiatry and clinical psychology accepts articles on these topics. Academic Journal of Neuropsychiatry and Neuropsychology publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

eISSN: 3108-8171
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Electroclinical aspects of diabetic neuropathy in the city of Ouagadougou
Abstract
Aims: Diabetic neuropathy (DN) is one of the most common microvascular complications of diabetes mellitus, often leading to severe sensorimotor disability. This study aimed to identify factors associated with the severity of electroneuromyographic (ENMG) involvement among diabetic patients followed in Ouagadougou, Burkina Faso.
Methods: We conducted a cross-sectional analytical study including 64 patients with clinically diagnosed DN who underwent electrodiagnostic (EDX) evaluation. Sociodemographic, clinical, and biological data were collected. Neuropathy severity was classified as mild/moderate or severe/very severe. Bivariate and multivariate logistic regression analyses were performed, with a significance level set at p<0.05.
Results: The mean age was 64.6±8 years, with a slight female predominance (53.1%). In bivariate analysis, severe EDX involvement was significantly associated with a diabetes duration ≥10 years [OR=6.55; 95% CI (1.95-21.9); p=0.002] and age ≥65 years [OR=3.33; 95% CI (1.15-9.61); p=0.024]. In multivariate analysis, only diabetes duration ≥10 years remained an independent predictor of severity [adjusted OR=5.32; 95% CI (1.52-18.5); p=0.009].
Conclusion: The severity of DN was mainly linked to long-standing diabetes, emphasizing the need for early screening and strict glycemic control.

Keywords : Diabetic neuropathy, electroneuromyography, severity, associated factors, Burkina Faso

Download Article


1. Said G. Diabetic neuropathy. Handb Clin Neurol. 2013;115:579-589. doi:10.1016/B978-0-444-52902-2.00033-3
2. Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med. 1998;15(6):508-514. doi:10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L
3. Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005; 28(4):956-962. doi:10.2337/diacare.28.4.956
4. Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-2293. doi:10.2337/dc10-1303
5. The DCCT Research Group. Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes. 1988;37(4):476-481. doi:10.2337/diab.37.4.476
6. Boulton AJM, Cavanagh PR, Rayman G, eds. The Foot in Diabetes. 4th ed. John Wiley & Sons; 2006. doi:10.1002/0470029374
7. Tracy JA, Dyck PJ. The spectrum of diabetic neuropathies. Phys Med Rehabil Clin N Am. 2008;19(1):1-v. doi:10.1016/j.pmr.2007.10.010
8. Hartemann A, Lozeron P. Peripheral neuropathies in diabetics. MCED. 2015;74:70-73.
9. Braffett BH, Gubitosi-Klug RA, Albers JW, et al. Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 2020; 69(5):1000-1010. doi:10.2337/db19-1046
10. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996;39(11):1377-1384. doi:10.1007/s001250050586
11. Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154. doi:10.2337/dc16-2042
12. Ziegler D, Strom A, Lobmann R, Reiners K, Rett K, Schnell O. High prevalence of diagnosed and undiagnosed polyneuropathy in subjects with and without diabetes participating in a nationwide educational initiative (PROTECT study). J Diabetes Complications. 2015;29(8):998-1002. doi:10.1016/j.jdiacomp.2015.09.008
13. Mather KJ, Bebu I, Baker C, et al. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes-A Comparative Effectiveness (GRADE) Study cohort. Diabetes Res Clin Pract. 2020;165:108235. doi:10.1016/j.diabres.2020.108235
14. Andersen ST, Witte DR, Dalsgaard EM, et al. Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark. Diabetes Care. 2018;41(5):1068-1075. doi:10.2337/dc17-2062
15. Dabilgou AA, Tieno H, Tiendrebeogo JZ, Yameogo VN, Zett CM, Millogo A. Frequency, risk factors and clinical forms of neuropathies in diabetics in hospitals in Burkina Faso. J Diabetes Mellitus. 2018;8(3):70-83. doi:10.4236/jdm.2018.83008
16. Fournier E. Practical Guide to Electromyography and Evoked Potentials. 3rd ed. Masson; 2018.
17. Fournier E. Manuel d’électromyographie. Lavoisier Médecine Sciences; 2021.
18. Baba M, Suzuki C, Ogawa Y. Severity grading system of diabetic neuropathy in type-2 diabetes by nerve conduction study: five-year prospective study on occurrence of diabetic foot, macroangiopathic events, and eventual death. Jpn J Clin Neurophysiol. 2018;46(2):71-77. doi:10.11422/jscn.46.71
19. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. International Diabetes Federation; 2021.
20. Motala AA, Mbanya JC, Ramaiya K, Pirie FJ, Ekoru K. Type 2 diabetes mellitus in sub-Saharan Africa: challenges and opportunities. Nat Rev Endocrinol. 2022;18(4):219-229. doi:10.1038/s41574-021-00613-y
21. Kuate-Tegueu C, Temfack E, Ngankou S, Doumbe J, Djientcheu VP, Kengne AP. Prevalence and determinants of diabetic polyneuropathy in a sub-Saharan African referral hospital. J Neurol Sci. 2015;355(1-2):108-112. doi:10.1016/j.jns.2015.05.035
22. Maiga Y, Diallo S, Konipo FD, et al. Diabetic polyneuropathy with/out neuropathic pain in Mali: a cross-sectional study in two reference diabetes treatment centers in Bamako (Mali), Western Africa. PLoS One. 2020;15(11):e0241387. doi:10.1371/journal.pone.0241387
23. Liu X, Xu Y, An M, Zeng Q. The risk factors for diabetic peripheral neuropathy: a meta-analysis. PLoS One. 2019;14(2):e0212574. doi:10.1371/journal.pone.0212574
24. Carls G, Huynh J, Tuttle E, Yee J, Edelman SV. Achievement of glycated hemoglobin goals in the US remains unchanged through 2014. Diabetes Ther. 2017;8(4):863-873. doi:10.1007/s13300-017-0280-5
25. Fina Lubaki JP, Omole OB, Francis JM. Glycaemic control among type 2 diabetes patients in sub-Saharan Africa from 2012 to 2022: a systematic review and meta-analysis. Diabetol Metab Syndr. 2022;14:134. doi:10.1186/s13098-022-00902-0
26. Shiferaw WS, Akalu TY, Work Y, Aynalem YA. Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):49. doi:10.1186/s12902-020-0534-5
27. Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: a review. JAMA. 2015;314(20):2172-2181. doi:10.1001/jama.2015.13611
28. Fentie D, Solomon Y, Abebe F, Derese T, Tigstu F, Hailemariam T. Diabetic peripheral neuropathy and their associations with overweight/ obesity and impaired blood glucose among diabetic patients in eastern Ethiopia: institutional-based study. SAGE Open Med. 2023;11: 20503121231220784. doi:10.1177/20503121231220784
29. Chokote SE, Lemdjo G, Idiaquez Rios JF, et al. Clinical and electrophysiological characterization of diabetic neuropathy in a sub-Saharan African cohort. J Peripher Nerv Syst. 2025;30(2):e70021. doi:10.1111/jns.70021
30. Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41. doi:10.1038/s41572-019-0092-1
31. Feldman EL, Nave KA, Jensen TS, Bennett DLH. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron. 2017;93(6):1296-1313. doi:10.1016/j.neuron.2017.02.005
32. Elliott J, Sloan G, Stevens L, et al. Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study. Diabetologia. 2024;67(1):190-198. doi: 10.1007/s00125-023-06025-z
33. Tesfaye S, Kempler P. Conventional management and current guidelines for painful diabetic neuropathy. Diabetes Res Clin Pract. 2023;206(suppl 1):110765. doi:10.1016/j.diabres.2023.110765
34. Valensi P, Giroux C, Seeboth-Ghalayini B, Attali JR. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors. J Diabetes Complications. 1997;11(1):27-34. doi:10.1016/S1056-8727(95)00086-0
35. Amour AA, Chamba N, Kayandabila J, et al. Prevalence, patterns, and factors associated with peripheral neuropathies among diabetic patients at tertiary hospital in the Kilimanjaro Region: descriptive cross-sectional study from North-Eastern Tanzania. Int J Endocrinol. 2019;2019:5404781. doi:10.1155/2019/5404781
36. Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 2014;5(6):714-721. doi:10.1111/jdi.12223
37. Lamontagne A, Buchthal F. Electrophysiological studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry. 1970;33(4):442-452. doi:10.1136/jnnp.33.4.442
38. Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17(7):400-420. doi:10.1038/s41574-021-00496-z
39. Issar T, Arnold R, Kwai NCG, et al. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients. Clin Neurophysiol. 2019;130(11):2088-2095. doi:10.1016/j.clinph.2019.08.005
40. Jasti DB, Mallipeddi S, Apparao A, Vengamma B, Sivakumar V, Kolli S. A clinical and electrophysiological study of peripheral neuropathies in predialysis chronic kidney disease patients and relation of severity of peripheral neuropathy with degree of renal failure. J Neurosci Rural Pract. 2017;8(4):516-524. doi:10.4103/jnrp.jnrp_186_17
41. Kibirige D, Chamba N, Andia-Biraro I, et al. Indicators of optimal diabetes care and burden of diabetes complications in Africa: a systematic review and meta-analysis. BMJ Open. 2022;12(11):e060786. doi:10.1136/bmjopen-2022-060786
42. Negussie YM, Bekele NT. Diabetic peripheral neuropathy among adult type 2 diabetes patients in Adama, Ethiopia: health facility-based study. Sci Rep. 2024;14:3844. doi:10.1038/s41598-024-53951-y
Article available in :
Volume 3, Issue 3, 2026
Page : 50-57
https://doi.org/10.51271/AJNN-0052
Article Information
Received : 31 Mar 2026
Accepted : 24 Haz 2026
Published : 29 Eyl 2026
Corresponding Author :

Alassane Zoungrana: Department of Neurology, Souro Sanou University Hospital, Bobo-Dioulasso, Burkina Faso

[email protected]
Citation : Zoungrana A, Dabilgou AA, Kaboré MR, Millogo A. Electroclinical aspects of diabetic neuropathy in the city of Ouagadougou. Acad J Neuropsychiatry Neuropsychol. 2026;3(3):50-57. doi:10.51271/AJNN-0052

Read: 10
Download : 2
Cited: 0
_Footer